Targos Molecular Pathology GmbH
34119 Kassel, Hessen
Thomas Henkel, Chief Executive Officer
Company main phone:
+49 (561) 500450 Company main fax:
+49 (561) 50045355 Website: https://www.targos-gmbh.de
|Source of foundation:||Independent foundation|
|Name of foundation source:||Founded by Dr. Thomas Henkel, Prof. Josef Rüschoff and Dr. Reinhard Büttner.|
Corporate description / mission:
Targos’s core service business is to provide standardized development and application of clinical biomarkers for the international pharmaceutical and diagnostic industry. The company also supports the introduction of new Companion Diagnostic assays into the clinical routine by performing Targos Advance training courses for the international standardization of biomarkers. The company is a fully GCP-compliant central laboratory that is inspected by the U.S. Food and Drug Administration (FDA). Targos Molecular Pathology GmbH is accredited by the College of American Pathologists (CAP) and the Clinical Laboratory Improvement Amendments (CLIA).
State of ownership: Private / independent
- Biotechnology - R&D Services
- Large biotech & big pharma
- Small biotech
Summary Products / Services / Technologies
Description of products:
In Situ Hybridization (ISH), etc.
Collaborations & Clients
Partnering strategy / collaborations:
WuXi PharmaTech, China
Pathologie Nordhessen, Germany
Institute of Pathology, University Hospital Cologne, Germany
Department of Pathology, University Medical Center Göttingen (UMG), Germany.